Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Ruanne V. Barnabas(University of Washington), Helen Y. Chu(University of Washington), Risa M. Hoffman(University of California, Los Angeles), Katherine K. Thomas(University of Namur), Helen C. Stankiewicz Karita(University of Washington), Keith R. Jerome(Infectious Disease Research Institute), Meei‐Li Huang(Infectious Disease Research Institute), Susan Morrison, Miriam K. Laufer(University of Maryland, Baltimore), Harald S. Haugen, Patricia Kissinger(Tulane University), Raphael J. Landovitz(APLA Health), Michael K. Paasche‐Orlow(Boston University), Kathleen M. Neuzil(University of Maryland, Baltimore), Anna Wald(University of Namur), Mark H. Wener(University of Washington), Anna Bershteyn(New York University), Angelica C Kottkamp(New York University), Meagan E. Deming(University of Maryland, Baltimore), Lara Kidoguchi, Alexander L. Greninger(University of Washington), Jared M. Baeten(University of Namur), Kristopher Paolino(Walter Reed National Military Medical Center), Torin Schaafsma(University of Washington), Alfred Luk(Tulane University), Christine Johnston(University of Washington), Lorna E. Thorpe(New York University), Connie Celum(University of Namur), Meighan Krows, Elizabeth R. Brown(Fred Hutch Cancer Center)
Cited by 93
Related Papers
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|847
Detection of SARS-CoV-2 with SHERLOCK One-Pot Testing
|New England Journal of Medicine|2020|801